Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Medical Dialogues Bureau
    Medical Dialogues Bureau

      Medical Dialogues Bureau consists of a team of passionate medical/scientific writers, led by doctors and healthcare researchers.  Our team efforts to bring you updated and timely news about the important happenings of the medical and healthcare sector. Our editorial team can be reached at editorial@medicaldialogues.in. Check out more about our bureau/team here

      • Home
      • Medical Dialogues...

      Articles By : Medical Dialogues Bureau

      Lupin gets market approval of Atovaquone oral suspension By USFDA

      Lupin gets market approval of Atovaquone oral suspension By USFDA

      Medical Dialogues Bureau13 Sept 2018 2:06 PM IST
      Atovaquone oral suspension used for prevention and treatment of a type of pneumonia.New Delhi: Drug firm Lupin said it has received a approval from...
      Merck KGaA, Pfizer develop Bavencio immuno-drug to alleviate kidney cancer

      Merck KGaA, Pfizer develop Bavencio immuno-drug to alleviate kidney cancer

      Medical Dialogues Bureau13 Sept 2018 2:03 PM IST
      FRANKFURT: Merck KGaA said that its immunotherapy Bavencio, jointly developed with Pfizer, delayed the progression of kidney cancer when used in...
      Foamix Pharmaceutical acne drug meets Goal in late stage trial

      Foamix Pharmaceutical acne drug meets Goal in late stage trial

      Medical Dialogues Bureau13 Sept 2018 2:02 PM IST
      Foamix Pharmaceutical recently announced that its drug for treating moderate-to-severe acne has met the main goals of its third late-stage study....
      Alcon, Eye Care Unit of Novartis picks Geneva over Texas for new HQ

      Alcon, Eye Care Unit of Novartis picks Geneva over Texas for new HQ

      Medical Dialogues Bureau13 Sept 2018 9:21 AM IST
      ZURICH: The headquarters of Alcon, the eye care unit of Novartis which will be spun off to shareholders in 2019, will move from the division's...
      328 FDC Medicines banned over safety concern: Health Ministry Notification

      328 FDC Medicines banned over safety concern: Health Ministry Notification

      Medical Dialogues Bureau12 Sept 2018 5:20 PM IST
      DTAB recommended, amongst other things, that there is no therapeutic justification for the ingredients contained in 328 FDCs and that these FDCs may...
      Sun Pharma: USFDA Scrutinizes Mohali plant in Punjab

      Sun Pharma: USFDA Scrutinizes Mohali plant in Punjab

      Medical Dialogues Bureau12 Sept 2018 1:43 PM IST
      New Delhi: Drug major Sun Pharmaceutical Industries said the US health regulator is conducting an inspection of its Mohali facility in Punjab. The...
      J&J case: Health Ministry asks victims to approach central or state panel

      J&J case: Health Ministry asks 'victims' to approach central or state panel

      Medical Dialogues Bureau12 Sept 2018 1:41 PM IST
      They may send an email to legalcell@cdsco.nic.in.NEW DELHI: The Health Ministry issued a public notice stating that patients suffering from the...
      Zydus Cadila gets tentative USFDA approval for diabetes drug

      Zydus Cadila gets tentative USFDA approval for diabetes drug

      Medical Dialogues Bureau12 Sept 2018 10:23 AM IST
      Zydus Cadila has received tentative approval from the US health regulator to market Sitagliptin tablets, indicated for treating diabetes, in the...
      Glenmark Pharma gets Marketing Authorisation for generic version of COPD drug in Germany

      Glenmark Pharma gets Marketing Authorisation for generic version of COPD drug in Germany

      Medical Dialogues Bureau12 Sept 2018 9:22 AM IST
      It is used to treat asthma and chronic obstructive pulmonary disease (COPD).New Delhi: Glenmark Pharma's subsidiary has secured marketing...
      Suprise Visit check by CDSCO finds banned Oxytocin in East Delhi

      Suprise Visit check by CDSCO finds banned Oxytocin in East Delhi

      Medical Dialogues Bureau11 Sept 2018 4:37 PM IST
      New Delhi: A chemist shop in the East Delhi's Gazipur area has come into the limelight after a raid by Central Drug Standard Control Organization...
      Johnson and Johnson, Health Ministry to meet to Discuss compensation to faulty implant victims

      Johnson and Johnson, Health Ministry to meet to Discuss compensation to faulty implant victims

      Medical Dialogues Bureau11 Sept 2018 12:55 PM IST
      Some of the patients who had suffered due to faulty hip implants had questioned the panel's recommendation of the paltry amount, saying it was like...
      Sun Pharma  to acquire shares of Israeli firm Tarsius Pharma for Rs 21 crore

      Sun Pharma to acquire shares of Israeli firm Tarsius Pharma for Rs 21 crore

      Medical Dialogues Bureau11 Sept 2018 11:57 AM IST
      Tarsius is an early stage research and development company focusing on the development of drug candidates in the field of ophthalmology, it added.New...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok